Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)

NCT03697993 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

62

Enrollment

NIH

Sponsor class

Stopped inadequate enrollment.

Conditions

Urinary Tract Infection

Interventions

DRUG: Fosfomycin tromethamine
DRUG: Levofloxacin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)